CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-20 | SATO VICKI L Director | Sale | −5,200 | $55.38 | $288K | 1,554,593 |
| 2021-12-20 | SATO VICKI L Director | Sale | −1,100 | $56.10 | $62K | 1,553,493 |
| 2021-12-20 | SATO VICKI L Director | Sale | −2,401 | $57.82 | $139K | 1,551,092 |
| 2021-12-15 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $1.53 | $8K | 97,777 |
| 2021-12-15 | Pang Phillip Chief Medical Officer | Sale | −1,716 | $49.41 | $85K | 96,061 |
| 2021-12-15 | Pang Phillip Chief Medical Officer | Sale | −1,050 | $50.60 | $53K | 95,011 |
| 2021-12-15 | Pang Phillip Chief Medical Officer | Sale | −1,034 | $51.30 | $53K | 93,977 |
| 2021-12-15 | Pang Phillip Chief Medical Officer | Sale | −1,200 | $52.20 | $63K | 92,777 |
| 2021-12-15 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 72,591 | ||
| 2021-12-15 | Virgin Herbert EVP, Research & CSO | Option exercise | +2,750 | $1.53 | $4K | 110,450 |
| 2021-12-15 | Virgin Herbert EVP, Research & CSO | Sale | −2,750 | $50.00 | $138K | 107,700 |
| 2021-12-15 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −2,750 | 226,380 | ||
| 2021-12-14 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 109,075 |
| 2021-12-14 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $45.88 | $63K | 107,700 |
| 2021-12-14 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 229,130 | ||
| 2021-12-01 | Pang Phillip Chief Medical Officer | Sale | −950 | $41.82 | $40K | 99,327 |
| 2021-12-01 | Pang Phillip Chief Medical Officer | Sale | −4,409 | $43.46 | $192K | 94,918 |
| 2021-12-01 | Pang Phillip Chief Medical Officer | Sale | −2,050 | $44.10 | $90K | 92,868 |
| 2021-12-01 | Pang Phillip Chief Medical Officer | Sale | −91 | $44.97 | $4K | 92,777 |
| 2021-11-30 | Virgin Herbert EVP, Research & CSO | Option exercise | +15,125 | $1.53 | $23K | 122,825 |
Page 32 of 54 · 1,063 trades